Source:http://www4.wiwiss.fu-berlin.de/dailymed/resource/drugs/2729
| Predicate | Object |
|---|---|
| rdf:type | |
| rdfs:label |
Norgesic (Tablet, Multilayer)
|
| dailymed-instance:dosage |
Norgesic: Adults 1 to 2 tablets 3 to 4 times daily. Norgesic Forte: Adults��to 1 tablet 3 to 4 times daily.
|
| dailymed-instance:activeIng... | |
| dailymed-instance:contraind... |
Because of the mild anticholinergic effect of orphenadrine, Norgesic or Norgesic Forte should not be used in patients with glaucoma, pyloric or duodenal obstruction, achalasia, prostatic hypertrophy or obstructions at the bladder neck. Norgesic or Norgesic Forte is also contraindicated in patients with myasthenia gravis and in patients known to be sensitive to aspirin or caffeine. The drug is contraindicated in patients who have demonstrated a previous hypersensitivity to the drug.
|
| dailymed-instance:supply |
Norgesic tablets can be identified by their two layers colored white and yellow. Each round tablet is embossed���NORGESIC���on one side and���3M���on the other and contains orphenadrine citrate (2-dimethylaminoethyl 2-methylbenzhydryl ether citrate) 25 mg, aspirin 385 mg, and caffeine 30 mg. Norgesic Forte tablets are exactly twice the strength of Norgesic. They are identified by their scored capsule shape and by their two layers colored white and yellow. Each capsule shaped tablet is embossed���NORGESIC FORTE���on one side and���3M���on the other and contains orphenadrine citrate 50 mg, aspirin 770 mg, and caffeine 60 mg. Norgesic and Norgesic Forte also contain: lactose, polyethylene glycol, povidone, starch, sucrose, zinc stearate, and D&C yellow #10. Norgesic: Bottles of 100 tablets (NDC 0089-0231-10) and 500 tablets (NDC 0089-0231-50). Norgesic Forte: Bottles of 100 tablets (NDC 0089-0233-10) and 500 tablets (NDC 0089-0233-50). Store below 30��C (86��F). Rx only 600600 MAY 1998 3M Pharmaceuticals Northridge, CA 91324
|
| dailymed-instance:activeMoi... | |
| dailymed-instance:inactiveI... | |
| dailymed-instance:precautio... |
Confusion, anxiety and tremors have been reported in a few patients receiving propoxyphene and orphenadrine concomitantly. As these symptoms may be simply due to an additive effect, reduction of dosage and/or discontinuation of one or both agents is recommended in such cases. Safety of continuous long term therapy with Norgesic and Norgesic Forte has not been established; therefore, if Norgesic or Norgesic Forte is prescribed for prolonged use, periodic monitoring of blood, urine and liver function values is recommended.
|
| dailymed-instance:genericMe... |
orphenadrine citrate, aspirin and caffeine
|
| dailymed-instance:fullName |
Norgesic (Tablet, Multilayer)
|
| dailymed-instance:adverseRe... |
Side effects of Norgesic or Norgesic Forte are those seen with aspirin and caffeine or those usually associated with mild anticholinergic agents. These may include tachycardia, palpitation, urinary hesitancy or retention, dry mouth, blurred vision, dilatation of the pupil, increased intraocular tension, weakness, nausea, vomiting, headache, dizziness, constipation, drowsiness, and rarely, urticaria and other dermatoses. Infrequently, an elderly patient may experience some degree of confusion. Mild central excitation and occasional hallucinations may be observed. These mild side effects can usually be eliminated by reduction in dosage. One case of aplastic anemia associated with the use of Norgesic has been reported. No causal relationship has been established. Rare G.I. hemorrhage due to aspirin content may be associated with the administration of Norgesic or Norgesic Forte. Some patients may experience transient episodes of light-headedness, dizziness or syncope.
|
| dailymed-instance:warning |
Reye's Syndrome may develop in individuals who have chicken pox, influenza, or flu symptoms. Some studies suggest a possible association between the development of Reye's Syndrome and the use of medicines containing salicylate or aspirin. Norgesic and Norgesic Forte contain aspirin and therefore are not recommended for use in patients with chicken pox, influenza, or flu symptoms. Norgesic and Norgesic Forte may impair the ability of the patient to engage in potentially hazardous activities such as operating machinery or driving a motor vehicle; ambulatory patients should therefore be cautioned accordingly. Aspirin should be used with extreme caution in the presence of peptic ulcers and coagulation abnormalities.
|
| dailymed-instance:represent... | |
| dailymed-instance:routeOfAd... | |
| dailymed-instance:name |
Norgesic
|